Oct. 11–12, 2021 • Online
- Susan M. Kaech, PhD – Salk Institute
- Anne O'Garra, PhD – The Francis Crick Institute
- Aaron M. Ring, MD, PhD – Yale University
The safety of our attendees at our in-person events is of the utmost importance at the Society for Immunotherapy of Cancer (SITC). Given the recent increase in the COVID-19 virus and the desire to keep everyone as safe as possible, the Cytokines in Cancer Immunotherapy Workshop, Oct. 11-12, 2021 will now be held virtually.
SITC invites you to attend the virtual workshop, Cytokines in Cancer Immunotherapy. This workshop will provide a deeper understanding of cytokines in immune cell proliferation, differentiation, and function, as they pertain to tumor immunobiology and cancer immunotherapy approaches. The virtual format assures a compelling program that can be held safely and successfully, and allows us to accommodate as many participants as possible.
To thank you for your continued interest in this workshop given the postponement in 2020 and now a switch to a virtual format, we are happy to be able to offer a 50 percent discount on the registration rate. Register today at the special new rate!
The workshop will consist of scientific sessions and expert-led discussion on pressing topics in the field of cytokines in immunology and cancer immunotherapy. This workshop will encourage further investigation into the use of cytokines as solo therapeutic agents as well as in combination with cancer treatments by bringing together established experts and drawing talented new scientists and clinicians into the area of cytokines and immune cell differentiation and function.
It is anticipated that the efforts of this workshop will foster renewed exchange and research on the promising topic of cytokines and their interactions in cancer development and therapy, lead to further research, and provide a solid scientific foundation for future clinical interventions to modulate anti-tumor immunity with combinations of cytokines and other immunotherapies.
Topics to be discussed will include:
- History of cytokine immunotherapy
- Paradox of IL-10
- Inhibitory cytokines
- Interferons: Friend or foe?
- Clinical trials with cytokines
- Emerging cytokine therapies
- Cytokines in cellular therapies
- Cytokines in innate immunity
- Describe the mechanisms of cytokines in the differentiation, activation and function of immune cells
- Summarize current clinical and preclinical studies of cytokines as cancer immunotherapies and in combination with other cancer therapies
- Explain the use of cytokines in adoptive cellular therapies
abstracT Award Winners
SITC is pleased to announce the Cytokines in Cancer Immunotherapy Virtual Workshop Abstract Award Winners to four early career scientists.
The following individuals were judged to be the top two presenters in their presentation category:
Oral Abstract Winners
Brendan L. Horton, PhD – Massachusetts Institute of Technology
Natalie K. Wolf – University of California Berkeley
Minute to Win It Winners
Margarida Saraiva, PhD – I3S - University of Porto
Jaroslav Zak, DPhil, PhD – The Scripps Research Institute